Glp-1 Dose Adjustments Based On Patient Engagement

Insulin dose adjustments with add

Glucagon-like peptide-1 receptor agonists ( GLP -1RAs) are gaining ground as therapeutic modalities in combination with insulin in patients with type 2 diabetes mellitus. Exploiting the multiple benefits of incretin- based therapies in certain patient populations, especially in those who would bene-fit most from potential weight loss or prevention of body weight gain, has provided a valuable add ...

Furthermore, visual representations like the one above help us fully grasp the concept of Glp-1 Dose Adjustments Based On Patient Engagement.

Oral GLP1 Adherence and Monitoring Insights

Furthermore, visual representations like the one above help us fully grasp the concept of Glp-1 Dose Adjustments Based On Patient Engagement.

With less frequent dosing, it's even more important to adjust clinical monitoring and keep patients engaged to help them stay consistent with their oral GLP‑1 treatment.

ANZCA and peak diabetes, obesity and gastroenterological bodies have produced an updated set of clinical practice recommendations for patients using GLP-1 receptor agonists and dual GLP-1/GIP receptor co-agonists. The college has also developed a patient information sheet and a form for patients taking GLP-1 receptor agonists for the treatment of diabetes or for weight loss.